Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 5/20 | 0.33 |
| ▸ | CTSB | P07858 | 5/20 | 0.33 |
| ▸ | CTSS | P25774 | 5/20 | 0.33 |
| ▸ | CTSK | P43235 | 5/20 | 0.33 |
| ▸ | GCGR | P47871 | 6/20 | 0.32 |
| ▸ | GIPR | P48546 | 3/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26961664 | 0.88 | GCGR (0.35) | KCNN4CTSLCTSBCTSSCTSK | |
| SCHEMBL31143125 | 0.87 | SRC (0.36) | CTSLCTSBCTSSCTSKGCGR | |
| SCHEMBL26962505 | 0.85 | ABHD6 (0.33) | GCGRGIPRGRM2PDK2NPY1R | |
| SCHEMBL26961950 | 0.84 | GRM2 (0.32) | KCNN4GCGRGRM2 | |
| SCHEMBL26961949 | 0.83 | GRM2 (0.32) | KCNN4GCGRGIPRGRM2NPY1R | |
| SCHEMBL26961640 | 0.82 | NPY1R (0.35) | NPY1R | |
| SCHEMBL31628294 | 0.82 | P2RY14 (0.34) | GCGRNPY1R | |
| SCHEMBL26961932 | 0.81 | NPY1R (0.32) | PDK2NPY1R | |
| SCHEMBL26962164 | 0.81 | PDK2 (0.33) | PDK2NPY1R | |
| SCHEMBL26961809 | 0.80 | NPY1R (0.32) | NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |